フィルターを表示する
リソースの種類
フィルターで絞り込む リソースの種類
Pathologies
フィルターで絞り込む Pathologies
Technologies
フィルターで絞り込む Technologies
Instruments
フィルターで絞り込む Instruments
16 検索結果
並び替え:

HYDRASYS 2 SCAN FOCUSING: Overview

ビデオ
2月. 13, 2024

Learn more about the HYDRASYS 2 SCAN FOCUSING for a fast and user-friendly gel electrophoresis processing.

Sebia launches M-inSight®, a test for monitoring multiple myeloma patients

プレスリリース
12月. 04, 2023

Corgenix, a Sebia Group company, CAP/CLIA clinical laboratory, positions Sebia to globally commercialize M-inSight®, a novel non-invasive liquid biopsy assay for Minimal Residual Disease (MRD) monitoring in multiple myeloma

12月. 09, 2023 12月. 11, 2023

イベント
San Diego, CA

ASH 2023

Sebia booth: #2455

詳細はこちら

Challenges in Implementing Capillary Electrophoresis for Immunotyping

ウェビナー
3月. 29, 2023

Educational Webinar with Dr. Jack Maggiore from Loyola University Medical Center in Chicago, IL

Modern Approach to Screening for Monoclonal Gammopathies Using Digital Workflows

ウェビナー
2月. 23, 2023

Educational Webinar with Dr. Mark Zaydman from Washington University School of Medicine in St. Louis, MO

Sebia acquires Zeus Scientific

プレスリリース
10月. 12, 2022

The strategic acquisition reinforces Sebia’s product portfolio & strategy in autoimmunity

Performance of Immunotyping vs. Immunofixation for the Detection of Monoclonal Gammopathies

ウェビナー
9月. 30, 2022

Educational Webinar with Katie Thoren, PhD, Memorial Sloan Kettering Cancer Center